FPF
ARAV

FNY Partners Fund’s Aravive, Inc. Common Stock ARAV Stock Holding History

FNY Partners Fund’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-97
Closed -$12K – 1239
2017
Q1 		$12K Buy
+97
New +$10.2K ﹤0.01% 1063

Other funds holding ARAV

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FNY Partners Fund's ARAV Position: Q2 2017 in Review

FNY Partners Fund sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2017, closing a stake of 97 shares — an estimated $12K sold.

FNY Partners Fund first reported a position in ARAV in Q1 2017 and held it in 1 quarter. The position peaked at $12K in Q1 2017. 95 funds tracked by Wall St. Rank hold ARAV as of Q2 2017.

  • FNY Partners Fund reported no remaining Aravive, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 97 Aravive, Inc. Common Stock shares in Q2 2017, an estimated $12K.
  • FNY Partners Fund first reported a position in Aravive, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's Aravive, Inc. Common Stock position peaked at $12K in Q1 2017.
  • 95 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.